Scarborough General Hospital
13
3
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
7.7%
1 terminated/withdrawn out of 13 trials
80.0%
-6.5% vs industry average
15%
2 trials in Phase 3/4
50%
2 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients
Role: lead
Comparing AI Role-Play and Peer Role-Play for Informed Consent Training in Endoscopy: A Randomized Control Trial
Role: collaborator
COVID-19 Vaccine Boosters in Patients With CKD
Role: collaborator
ODYSSEE Kidney Health Trial
Role: collaborator
Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study
Role: collaborator
A Multi-centered Feedback and Education Intervention Designed to Reduce Inappropriate Transthoracic Echocardiograms
Role: collaborator
Toronto Thromboprophylaxis Patient Safety Initiative
Role: collaborator
Hemodialysis Infection Prevention Using Polysporin Ointment With Shower Technique in Satellite Centres Pilot Study
Role: collaborator
SNE1725: Can Oral Glutamine Facilitate Early Return of Gut Function
Role: lead
Appropriate Controlled Feeding: a Single Blinded Prospective Randomised Study
Role: lead
The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding
Role: collaborator
Clinical Trial Comparing Epidurals and Local Anaesthetic Wound Catheters in Patients Having Bowel Surgery
Role: lead
Ontario ICU Clinical Best Practices Demonstration Project
Role: collaborator
All 13 trials loaded